Composition for enhancing adrenomedullin gene expression
AssigneeHouse Wellness Foods Corporation
InventorsHaruka NAKANISHI, Kazuki ASADA, Tatsuya OHARA, Koutarou MUROYAMA
Life of this patent
Estimating the term…
Abstract
The present invention provides a composition having an action to enhance adrenomedullin gene expression. One or more embodiments of the present invention relate to a composition for enhancing adrenomedullin gene expression containing a TRPV1 agonist and a TRPA1 agonist as active ingredients. The TRPV1 agonist can be, for example, at least one selected from capsaicin, 6-shogaol, 6-gingerol and piperine. The TRPA1 agonist can be, for example, at least one selected from allyl isothiocyanate, cinnamaldehyde, diallyl disulfide, ASP7663 and oxylipin.
Claims6
A method for enhancing adrenomedullin gene expression, comprising administering a TRPV1 agonist and a TRPA1 agonist to a subject in need of enhancement of or being desirable to enhance adrenomedullin gene expression.
A method for enhancing adrenomedullin gene expression in cells in vivo or in vitro, comprising providing a TRPV1 agonist and a TRPA1 agonist to cells in vivo or in vitro.
Dependencies are inferred from the claim text.